Area of research
Pathology and Forensic Medicine · Oncology
Research interest
Research interests include Genetic factors in colorectal cancer, Colorectal Cancer Screening and Detection, Epigenetics and DNA Methylation, and Colorectal Cancer Treatments and Studies.
Enhancing human NK cell antitumor function by knocking out SMAD4 to counteract TGFβ and activin A suppression
Prediction of long-term recurrence-free and overall survival in early-onset colorectal cancer: the ENCORE multi-centre study
An artificial intelligence-assisted system versus white light endoscopy alone for adenoma detection in individuals with Lynch syndrome (TIMELY): an international, multicentre, randomised controlled trial
Mortality by age, gene and gender in carriers of pathogenic mismatch repair gene variants receiving surveillance for early cancer diagnosis and treatment: a report from the prospective Lynch syndrome database
Delphi Initiative for Early-Onset Colorectal Cancer (DIRECt) International Management Guidelines
A Liquid Biopsy Signature for the Detection of Patients With Early-Onset Colorectal Cancer
No Difference in Penetrance between Truncating and Missense/Aberrant Splicing Pathogenic Variants in MLH1 and MSH2: A Prospective Lynch Syndrome Database Study
Eflornithine plus Sulindac for Prevention of Progression in Familial Adenomatous Polyposis
Correction: Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database
Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database
Endoscopic management of polyposis syndromes: European Society of Gastrointestinal Endoscopy (ESGE) Guideline
Endoscopic management of Lynch syndrome and of familial risk of colorectal cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline
Association of a let-7 miRNA binding region of<i>TGFBR1</i>with hereditary mismatch repair proficient colorectal cancer (MSS HNPCC)
Prevalence of somatic mutl homolog 1 promoter hypermethylation in Lynch syndrome colorectal cancer
IGFBP3 Methylation Is a Novel Diagnostic and Predictive Biomarker in Colorectal Cancer
Risk of Cancer in Cases of Suspected Lynch Syndrome Without Germline Mutation
Curcumin Modulates DNA Methylation in Colorectal Cancer Cells
Genetic susceptibility variants associated with colorectal cancer prognosis
Identification of Lynch Syndrome Among Patients With Colorectal Cancer
A High Degree of LINE-1 Hypomethylation Is a Unique Feature of Early-Onset Colorectal Cancer
Susceptibility genetic variants associated with early-onset colorectal cancer